{"entity":{"type":"insider","cik":"0001252524","url":"/insider/0001252524","json_url":"/insider/0001252524.json","name":"EMSTER KURT VON","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":97,"n_filings":60,"first":"2004-02-23","last":"2023-09-29","span_basis":"filed_date"},"name_variants":[{"name":"EMSTER KURT VON","source":"filing","n_filings":60,"first_seen":"2004-02-23","last_seen":"2023-09-29"}],"transactions":[{"id":8578920,"accession":"0001062993-23-018622","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001062993-23-018622","line_url":"/filing/0001062993-23-018622#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":15921.0,"shares_display":"15,921","price_per_share":15.6821,"price_display":"15.68","price_state":"stated","total_value":249674.7141,"total_display":"249,674.71","total_whole":"249,675","shares_owned_after":90000.0,"shares_owned_after_display":"90,000","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-09-29","filed_date":"2023-09-29","scope":"insider"},{"id":8223940,"accession":"0001213900-23-029900","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001213900-23-029900","line_url":"/filing/0001213900-23-029900#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"Jasper Therapeutics, Inc.","issuer_ticker":"JSPR","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Voting Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":9075.0,"shares_display":"9,075","price_per_share":1.4903,"price_display":"1.49","price_state":"stated","total_value":13524.4725,"total_display":"13,524.47","total_whole":"13,524","shares_owned_after":21175.0,"shares_owned_after_display":"21,175","ownership_form":"D","is_10b5_1":null,"transaction_date":"2023-04-13","filed_date":"2023-04-14","scope":"insider"},{"id":5476007,"accession":"0001209191-21-033806","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-21-033806","line_url":"/filing/0001209191-21-033806#line-3","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":772727.0,"shares_display":"772,727","price_per_share":11.0,"price_display":"11.00","price_state":"stated","total_value":8499997.0,"total_display":"8,499,997.00","total_whole":"8,499,997","shares_owned_after":2960231.0,"shares_owned_after_display":"2,960,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-05-18","filed_date":"2021-05-18","scope":"insider"},{"id":5475998,"accession":"0001209191-21-033806","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-033806","line_url":"/filing/0001209191-21-033806#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"Vera Therapeutics, Inc.","issuer_ticker":"VERA","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Class A Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":17828.0,"shares_display":"17,828","price_per_share":12.0404,"price_display":"12.04","price_state":"stated","total_value":214656.2512,"total_display":"214,656.25","total_whole":"214,656","shares_owned_after":17828.0,"shares_owned_after_display":"17,828","ownership_form":"D","is_10b5_1":null,"transaction_date":"2021-05-17","filed_date":"2021-05-18","scope":"insider"},{"id":2209172,"accession":"0000905718-20-000595","txn_seq":5,"anchor":"line-5","filing_url":"/filing/0000905718-20-000595","line_url":"/filing/0000905718-20-000595#line-5","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"Vaxcyte, Inc.","issuer_ticker":"PCVX","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock, $0.001 par value per share","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":12500.0,"shares_display":"12,500","price_per_share":16.0,"price_display":"16.00","price_state":"stated","total_value":200000.0,"total_display":"200,000.00","total_whole":"200,000","shares_owned_after":4168718.0,"shares_owned_after_display":"4,168,718","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-06-16","filed_date":"2020-06-18","scope":"insider"},{"id":9206411,"accession":"0000905718-19-000065","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-19-000065","line_url":"/filing/0000905718-19-000065#line-1","is_derivative":false,"issuer_cik":"0001674416","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001674416","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":62925.0,"shares_display":"62,925","price_per_share":29.7047,"price_display":"29.70","price_state":"stated","total_value":1869168.2475,"total_display":"1,869,168.25","total_whole":"1,869,168","shares_owned_after":1171268.0,"shares_owned_after_display":"1,171,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2019-01-18","scope":"insider"},{"id":6817559,"accession":"0000905718-18-000979","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-18-000979","line_url":"/filing/0000905718-18-000979#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":53492.0,"shares_display":"53,492","price_per_share":7.4285,"price_display":"7.43","price_state":"stated","total_value":397365.322,"total_display":"397,365.32","total_whole":"397,365","shares_owned_after":131036.0,"shares_owned_after_display":"131,036","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-19","scope":"insider"},{"id":6254486,"accession":"0000905718-18-000981","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-18-000981","line_url":"/filing/0000905718-18-000981#line-2","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":69925.0,"shares_display":"69,925","price_per_share":29.7047,"price_display":"29.70","price_state":"stated","total_value":2077101.1475,"total_display":"2,077,101.15","total_whole":"2,077,101","shares_owned_after":1164268.0,"shares_owned_after_display":"1,164,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-18","filed_date":"2018-12-19","scope":"insider"},{"id":6817554,"accession":"0000905718-18-000979","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000979","line_url":"/filing/0000905718-18-000979#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88889.0,"shares_display":"88,889","price_per_share":8.17,"price_display":"8.17","price_state":"stated","total_value":726223.13,"total_display":"726,223.13","total_whole":"726,223","shares_owned_after":184528.0,"shares_owned_after_display":"184,528","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-19","scope":"insider"},{"id":6254482,"accession":"0000905718-18-000981","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000981","line_url":"/filing/0000905718-18-000981#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3009.0,"shares_display":"3,009","price_per_share":33.1662,"price_display":"33.17","price_state":"stated","total_value":99797.0958,"total_display":"99,797.10","total_whole":"99,797","shares_owned_after":1234193.0,"shares_owned_after_display":"1,234,193","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-12-17","filed_date":"2018-12-19","scope":"insider"},{"id":9206410,"accession":"0000905718-18-000561","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000561","line_url":"/filing/0000905718-18-000561#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":920.0,"shares_display":"920","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":11509.2,"total_display":"11,509.20","total_whole":"11,509","shares_owned_after":18316.0,"shares_owned_after_display":"18,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-11","scope":"insider"},{"id":6408254,"accession":"0000905718-18-000559","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000559","line_url":"/filing/0000905718-18-000559#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":920.0,"shares_display":"920","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":11509.2,"total_display":"11,509.20","total_whole":"11,509","shares_owned_after":18316.0,"shares_owned_after_display":"18,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider"},{"id":6179446,"accession":"0000905718-18-000554","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000554","line_url":"/filing/0000905718-18-000554#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":920.0,"shares_display":"920","price_per_share":12.51,"price_display":"12.51","price_state":"stated","total_value":11509.2,"total_display":"11,509.20","total_whole":"11,509","shares_owned_after":18316.0,"shares_owned_after_display":"18,316","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-06-05","filed_date":"2018-06-07","scope":"insider"},{"id":6286811,"accession":"0000905718-18-000518","txn_seq":9,"anchor":"line-9","filing_url":"/filing/0000905718-18-000518","line_url":"/filing/0000905718-18-000518","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":400000.0,"shares_display":"400,000","price_per_share":55.35638950725,"price_display":"55.36","price_state":"stated","total_value":22142555.8029,"total_display":"22,142,555.80","total_whole":"22,142,556","shares_owned_after":1320910.0,"shares_owned_after_display":"1,320,910","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-14","filed_date":"2018-05-15","scope":"insider","n_lines":6},{"id":6286798,"accession":"0000905718-18-000518","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0000905718-18-000518","line_url":"/filing/0000905718-18-000518","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":250000.0,"shares_display":"250,000","price_per_share":52.8396007628,"price_display":"52.84","price_state":"stated","total_value":13209900.1907,"total_display":"13,209,900.19","total_whole":"13,209,900","shares_owned_after":1645835.0,"shares_owned_after_display":"1,645,835","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-05-11","filed_date":"2018-05-15","scope":"insider","n_lines":3},{"id":6063388,"accession":"0000905718-18-000307","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000307","line_url":"/filing/0000905718-18-000307#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13353.0,"shares_display":"13,353","price_per_share":15.51,"price_display":"15.51","price_state":"stated","total_value":207105.03,"total_display":"207,105.03","total_whole":"207,105","shares_owned_after":273417.0,"shares_owned_after_display":"273,417","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-03-05","filed_date":"2018-03-07","scope":"insider"},{"id":6138346,"accession":"0000905718-18-000263","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000263","line_url":"/filing/0000905718-18-000263#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":68712.0,"shares_display":"68,712","price_per_share":14.49,"price_display":"14.49","price_state":"stated","total_value":995636.88,"total_display":"995,636.88","total_whole":"995,637","shares_owned_after":286770.0,"shares_owned_after_display":"286,770","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-15","filed_date":"2018-02-20","scope":"insider"},{"id":9206409,"accession":"0000905718-18-000260","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000260","line_url":"/filing/0000905718-18-000260#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162979.0,"shares_display":"162,979","price_per_share":13.69,"price_display":"13.69","price_state":"stated","total_value":2231182.51,"total_display":"2,231,182.51","total_whole":"2,231,183","shares_owned_after":355482.0,"shares_owned_after_display":"355,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-14","filed_date":"2018-02-16","scope":"insider"},{"id":6254468,"accession":"0000905718-18-000256","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-18-000256","line_url":"/filing/0000905718-18-000256#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":162979.0,"shares_display":"162,979","price_per_share":16.69,"price_display":"16.69","price_state":"stated","total_value":2720119.51,"total_display":"2,720,119.51","total_whole":"2,720,120","shares_owned_after":355482.0,"shares_owned_after_display":"355,482","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-14","filed_date":"2018-02-15","scope":"insider"},{"id":6254466,"accession":"0000905718-18-000256","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000256","line_url":"/filing/0000905718-18-000256#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":55078.0,"shares_display":"55,078","price_per_share":13.51,"price_display":"13.51","price_state":"stated","total_value":744103.78,"total_display":"744,103.78","total_whole":"744,104","shares_owned_after":518461.0,"shares_owned_after_display":"518,461","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-13","filed_date":"2018-02-15","scope":"insider"},{"id":6436710,"accession":"0000905718-18-000117","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000117","line_url":"/filing/0000905718-18-000117#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":40763.0,"shares_display":"40,763","price_per_share":12.35,"price_display":"12.35","price_state":"stated","total_value":503423.05,"total_display":"503,423.05","total_whole":"503,423","shares_owned_after":419693.0,"shares_owned_after_display":"419,693","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-07","filed_date":"2018-02-09","scope":"insider"},{"id":6569624,"accession":"0000905718-18-000115","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000115","line_url":"/filing/0000905718-18-000115#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":18831.0,"shares_display":"18,831","price_per_share":12.14,"price_display":"12.14","price_state":"stated","total_value":228608.34,"total_display":"228,608.34","total_whole":"228,608","shares_owned_after":460456.0,"shares_owned_after_display":"460,456","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-05","filed_date":"2018-02-07","scope":"insider"},{"id":6514623,"accession":"0000905718-18-000111","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-18-000111","line_url":"/filing/0000905718-18-000111#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":2000.0,"shares_display":"2,000","price_per_share":12.11,"price_display":"12.11","price_state":"stated","total_value":24220.0,"total_display":"24,220.00","total_whole":"24,220","shares_owned_after":479287.0,"shares_owned_after_display":"479,287","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-02","filed_date":"2018-02-05","scope":"insider"},{"id":6514620,"accession":"0000905718-18-000111","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000111","line_url":"/filing/0000905718-18-000111#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":88098.0,"shares_display":"88,098","price_per_share":12.15,"price_display":"12.15","price_state":"stated","total_value":1070390.7,"total_display":"1,070,390.70","total_whole":"1,070,391","shares_owned_after":481287.0,"shares_owned_after_display":"481,287","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-02-01","filed_date":"2018-02-05","scope":"insider"},{"id":6436707,"accession":"0000905718-18-000096","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-18-000096","line_url":"/filing/0000905718-18-000096#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":12300.0,"shares_display":"12,300","price_per_share":12.23,"price_display":"12.23","price_state":"stated","total_value":150429.0,"total_display":"150,429.00","total_whole":"150,429","shares_owned_after":569385.0,"shares_owned_after_display":"569,385","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-31","filed_date":"2018-02-01","scope":"insider"},{"id":6436703,"accession":"0000905718-18-000096","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000096","line_url":"/filing/0000905718-18-000096#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":85339.0,"shares_display":"85,339","price_per_share":12.22,"price_display":"12.22","price_state":"stated","total_value":1042842.58,"total_display":"1,042,842.58","total_whole":"1,042,843","shares_owned_after":581685.0,"shares_owned_after_display":"581,685","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-30","filed_date":"2018-02-01","scope":"insider"},{"id":6408247,"accession":"0000905718-18-000074","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000074","line_url":"/filing/0000905718-18-000074#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":39438.0,"shares_display":"39,438","price_per_share":12.18,"price_display":"12.18","price_state":"stated","total_value":480354.84,"total_display":"480,354.84","total_whole":"480,355","shares_owned_after":667024.0,"shares_owned_after_display":"667,024","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-25","filed_date":"2018-01-26","scope":"insider"},{"id":5956379,"accession":"0000905718-18-000070","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000070","line_url":"/filing/0000905718-18-000070#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":138253.0,"shares_display":"138,253","price_per_share":10.4,"price_display":"10.40","price_state":"stated","total_value":1437831.2,"total_display":"1,437,831.20","total_whole":"1,437,831","shares_owned_after":706462.0,"shares_owned_after_display":"706,462","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-22","filed_date":"2018-01-24","scope":"insider"},{"id":6063385,"accession":"0000905718-18-000064","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-18-000064","line_url":"/filing/0000905718-18-000064#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":130584.0,"shares_display":"130,584","price_per_share":10.25,"price_display":"10.25","price_state":"stated","total_value":1338486.0,"total_display":"1,338,486.00","total_whole":"1,338,486","shares_owned_after":844715.0,"shares_owned_after_display":"844,715","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-19","filed_date":"2018-01-22","scope":"insider"},{"id":6063381,"accession":"0000905718-18-000064","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000064","line_url":"/filing/0000905718-18-000064#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":13632.0,"shares_display":"13,632","price_per_share":10.21,"price_display":"10.21","price_state":"stated","total_value":139182.72,"total_display":"139,182.72","total_whole":"139,183","shares_owned_after":975299.0,"shares_owned_after_display":"975,299","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-18","filed_date":"2018-01-22","scope":"insider"},{"id":6474399,"accession":"0000905718-18-000045","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000045","line_url":"/filing/0000905718-18-000045#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4300.0,"shares_display":"4,300","price_per_share":10.21,"price_display":"10.21","price_state":"stated","total_value":43903.0,"total_display":"43,903.00","total_whole":"43,903","shares_owned_after":988931.0,"shares_owned_after_display":"988,931","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-09","scope":"insider"},{"id":6217852,"accession":"0000905718-18-000054","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000054","line_url":"/filing/0000905718-18-000054#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":65934.0,"shares_display":"65,934","price_per_share":22.75,"price_display":"22.75","price_state":"stated","total_value":1499998.5,"total_display":"1,499,998.50","total_whole":"1,499,999","shares_owned_after":1887202.0,"shares_owned_after_display":"1,887,202","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-11","scope":"insider"},{"id":6012316,"accession":"0000905718-18-000047","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000047","line_url":"/filing/0000905718-18-000047#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":92337.0,"shares_display":"92,337","price_per_share":26.96,"price_display":"26.96","price_state":"stated","total_value":2489405.52,"total_display":"2,489,405.52","total_whole":"2,489,406","shares_owned_after":1821268.0,"shares_owned_after_display":"1,821,268","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-05","filed_date":"2018-01-09","scope":"insider"},{"id":6179438,"accession":"0000905718-18-000020","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-18-000020","line_url":"/filing/0000905718-18-000020#line-1","is_derivative":false,"issuer_cik":"0001252524","issuer_name":"CRISPR Therapeutics AG","issuer_ticker":"CRSP","issuer_name_source":null,"issuer_url":"/issuer/0001252524","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Shares","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37754.0,"shares_display":"37,754","price_per_share":26.7554,"price_display":"26.76","price_state":"stated","total_value":1010123.3716,"total_display":"1,010,123.37","total_whole":"1,010,123","shares_owned_after":1913605.0,"shares_owned_after_display":"1,913,605","ownership_form":"I","is_10b5_1":null,"transaction_date":"2018-01-02","filed_date":"2018-01-04","scope":"insider"},{"id":4927874,"accession":"0000905718-17-001042","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-001042","line_url":"/filing/0000905718-17-001042#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":173192.0,"shares_display":"173,192","price_per_share":9.4075,"price_display":"9.41","price_state":"stated","total_value":1629303.74,"total_display":"1,629,303.74","total_whole":"1,629,304","shares_owned_after":993231.0,"shares_owned_after_display":"993,231","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-12-22","filed_date":"2017-12-27","scope":"insider"},{"id":4352678,"accession":"0000905718-17-000974","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-000974","line_url":"/filing/0000905718-17-000974#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":50048.0,"shares_display":"50,048","price_per_share":9.2587,"price_display":"9.26","price_state":"stated","total_value":463379.4176,"total_display":"463,379.42","total_whole":"463,379","shares_owned_after":1166423.0,"shares_owned_after_display":"1,166,423","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-10","filed_date":"2017-11-14","scope":"insider"},{"id":4809738,"accession":"0000905718-17-000942","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-000942","line_url":"/filing/0000905718-17-000942#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":4320.0,"shares_display":"4,320","price_per_share":9.2545,"price_display":"9.25","price_state":"stated","total_value":39979.44,"total_display":"39,979.44","total_whole":"39,979","shares_owned_after":1216471.0,"shares_owned_after_display":"1,216,471","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-11-01","filed_date":"2017-11-03","scope":"insider"},{"id":4257273,"accession":"0000905718-17-000938","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-17-000938","line_url":"/filing/0000905718-17-000938#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":52573.0,"shares_display":"52,573","price_per_share":9.27,"price_display":"9.27","price_state":"stated","total_value":487351.71,"total_display":"487,351.71","total_whole":"487,352","shares_owned_after":1220791.0,"shares_owned_after_display":"1,220,791","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-31","filed_date":"2017-11-01","scope":"insider"},{"id":4257271,"accession":"0000905718-17-000938","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-000938","line_url":"/filing/0000905718-17-000938#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6636.0,"shares_display":"6,636","price_per_share":9.26,"price_display":"9.26","price_state":"stated","total_value":61449.36,"total_display":"61,449.36","total_whole":"61,449","shares_owned_after":1273364.0,"shares_owned_after_display":"1,273,364","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-30","filed_date":"2017-11-01","scope":"insider"},{"id":4299058,"accession":"0000905718-17-000867","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-17-000867","line_url":"/filing/0000905718-17-000867#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":70940.0,"shares_display":"70,940","price_per_share":7.81,"price_display":"7.81","price_state":"stated","total_value":554041.4,"total_display":"554,041.40","total_whole":"554,041","shares_owned_after":1280000.0,"shares_owned_after_display":"1,280,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-03","filed_date":"2017-10-04","scope":"insider"},{"id":4299046,"accession":"0000905718-17-000867","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-000867","line_url":"/filing/0000905718-17-000867#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":37936.0,"shares_display":"37,936","price_per_share":7.93,"price_display":"7.93","price_state":"stated","total_value":300832.48,"total_display":"300,832.48","total_whole":"300,832","shares_owned_after":1350940.0,"shares_owned_after_display":"1,350,940","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-10-02","filed_date":"2017-10-04","scope":"insider"},{"id":5114821,"accession":"0000905718-17-000853","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0000905718-17-000853","line_url":"/filing/0000905718-17-000853#line-2","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":120735.0,"shares_display":"120,735","price_per_share":8.04,"price_display":"8.04","price_state":"stated","total_value":970709.4,"total_display":"970,709.40","total_whole":"970,709","shares_owned_after":1388876.0,"shares_owned_after_display":"1,388,876","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-29","filed_date":"2017-10-02","scope":"insider"},{"id":5114815,"accession":"0000905718-17-000853","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000905718-17-000853","line_url":"/filing/0000905718-17-000853#line-1","is_derivative":false,"issuer_cik":"0001042074","issuer_name":"CymaBay Therapeutics, Inc.","issuer_ticker":"CBAY","issuer_name_source":null,"issuer_url":"/issuer/0001042074","owner_cik":"0001252524","owner_name":"EMSTER KURT VON","owner_display_name":"EMSTER KURT VON","owner_url":"/insider/0001252524","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":90389.0,"shares_display":"90,389","price_per_share":8.15,"price_display":"8.15","price_state":"stated","total_value":736670.35,"total_display":"736,670.35","total_whole":"736,670","shares_owned_after":1509611.0,"shares_owned_after_display":"1,509,611","ownership_form":"I","is_10b5_1":null,"transaction_date":"2017-09-28","filed_date":"2017-10-02","scope":"insider"}],"collapsed":true,"next_cursor":"2017-09-28|5114815","ledger_fault":false,"count":{"value":96,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":88,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":96},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001042074","name":"CymaBay Therapeutics, Inc.","url":"/issuer/0001042074","role":"Director","n_filings":23,"first_seen":"2017-10-02","last_seen":"2023-09-29"},{"type":"issuer","type_label":"ISSUER","cik":"0001788028","name":"Jasper Therapeutics, Inc.","url":"/issuer/0001788028","role":"Director","n_filings":1,"first_seen":"2023-04-14","last_seen":"2023-04-14"},{"type":"issuer","type_label":"ISSUER","cik":"0001831828","name":"Vera Therapeutics, Inc.","url":"/issuer/0001831828","role":"Director","n_filings":1,"first_seen":"2021-05-18","last_seen":"2021-05-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001649094","name":"Vaxcyte, Inc.","url":"/issuer/0001649094","role":"Director","n_filings":1,"first_seen":"2020-06-18","last_seen":"2020-06-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001674416","name":"CRISPR Therapeutics AG","url":"/issuer/0001674416","role":"Director","n_filings":25,"first_seen":"2017-02-10","last_seen":"2019-01-18"},{"type":"issuer","type_label":"ISSUER","cik":"0001339455","name":"Somaxon Pharmaceuticals, Inc.","url":"/issuer/0001339455","role":"Director","n_filings":8,"first_seen":"2005-12-20","last_seen":"2012-09-06"},{"type":"issuer","type_label":"ISSUER","cik":"0001034842","name":"RIGEL PHARMACEUTICALS INC","url":"/issuer/0001034842","role":"Ten percent owner","n_filings":1,"first_seen":"2004-02-23","last_seen":"2004-02-23"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001252524","retrieved_at":"2026-08-25T02:54:47+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}